Gen-Probe, Inc. (NASDAQ:GPRO)
$46.57
0.07 (+0.15%)
| CAPS Rating |
|
|---|---|
| Open | $46.48 |
| Previous Close | $46.50 |
| Daily Range | $45.94 - $46.57 |
| 52-Week Range | $35.69 - $49.29 |
| Market Cap | $2.30B |
| P/E Ratio | 25.55 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 181,813 |
| Average Daily Volume | 0 |
GPRO
VS S&P 500 (SPY)
How do you think GPRO will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GPRO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GPRO News and Commentary
- UPDATE 1-Gen-Probe 4th-quarter net rises 14 percent – Reuters
- UPDATE 1-Gen-Probe to acquire flu test maker for $60 mln – Reuters
- 5-Star Stocks on the Upswing – The Motley Fool
- Funds Cleaning House – The Motley Fool
- 7 Highly Rated Stocks on Sale – The Motley Fool
- Beat This Stock! – The Motley Fool
- Beat This Stock! – The Motley Fool
- Hot Stocks You're Buying Now – The Motley Fool
Related News and Articles
- This Just In: Upgrades and Downgrades – The Motley Fool
- 5-Star Stocks Poised to Pop: CryoLife – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Investing for All the Wrong Reasons – The Motley Fool
- Medtronic Needs to Regrow a Spine – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- 5-Star Stocks Poised to Pop: Becton Dickinson – The Motley Fool
- Too Bad It's Not in the "Restructuring" Business – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- What Bipartisan Health-Care Reform Means for Investors – The Motley Fool
RSS Headlines
Fool UK
